Clinical Trials Directory

Trials / Sponsors / Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)

Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)

Industry · 7 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnSafety and PK Trial Evaluating the Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of
Normal Healthy Volunteers
Phase 12018-04-01
CompletedEvaluating the Plasma, Epithelial Lining, and Alveolar Macrophage Concentrations of Intravenous Carbavance™ (R
Healthy Subjects
Phase 12014-02-01
CompletedThe Safety and Pharmacokinetics of Carbavance™ (RPX2014/RPX7009) in Subjects With Renal Insufficiency
Subjects With Varying Degrees of Renal Insufficiency and, Subjects With Normal Renal Function
Phase 12014-01-01
CompletedSafety, Tolerability, Pharmacokinetics of Intravenous RPX2014 and RPX7009 in Healthy Adult Subjects
Healthy Volunteers, Bacterial Infections
Phase 12013-07-01
CompletedSafety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination
Healthy Volunteers, Bacterial Infections
Phase 12013-03-01
CompletedSafety, Tolerability, Pharmacokinetics of Intravenous RPX7009 in Healthy Adult Subjects
Healthy Volunteers, Bacterial Infections
Phase 12012-12-01
CompletedSafety, Tolerability, Pharmacokinetics of Intravenous RPX2003 (Biapenem) in Healthy Adult Subjects
Healthy Volunteers, Bacterial Infections
Phase 12012-08-01